𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer

✍ Scribed by Sun, J.- M.; Ahn, Y. C.; Choi, E. K.; Ahn, M.- J.; Ahn, J. S.; Lee, S.- H.; Lee, D. H.; Pyo, H.; Song, S. Y.; Jung, S.- H.; Jo, J. S.; Jo, J.; Sohn, H. J.; Suh, C.; Lee, J. S.; Kim, S.- W.; Park, K.

Book ID
121340458
Publisher
Oxford University Press
Year
2013
Tongue
English
Weight
155 KB
Volume
24
Category
Article
ISSN
0923-7534

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II trial of irinotecan and cisplat
Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer
✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,